Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs

NCT07303556 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Diabete Type 2
Arterial Hypertension

Interventions

DRUG: Tirzepatide (Mounjaro)
DRUG: dapagliflozin, empagliflozin, metformin

Sponsor

Nazarbayev University